Article Information
History
- March 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Thomas Shin, MA, MPH1,2,*,
- Jason KH Lee, MSc Mbiotech, PhD, (Candidate)1,3,α,
- Alexia Kieffer, MSc, MPH, PhD4,
- Michael Greenberg, MD, MPH4 and
- Jianhong Wu, PhD2
- 1Sanofi, 1755 Steeles Ave W, North York, Ontario, Canada M2R 3T4
- 2York University, Department of Mathematics and Statistics N520 Ross, 4700 Keele Street, Toronto, Ontario, Canada M3J 1P3
- 3Leslie Dan School of Pharmacy, University of Toronto, 144 College St, Toronto, Ontario, Canada M5S 3M2
- 4Sanofi, Lyon, France
- ↵*Corresponding author:
thomas.shin{at}sanofi.com
Posted March 28, 2024.
A Health Economic Evaluation for Implementing an Extended Half-life Monoclonal Antibody for All Infants vs. Standard Care for Respiratory Virus Syncytial Prophylaxis in Canada
